Agios Pharmaceuticals Inc to Present Mitapivat Clinical Data at EHA Virtual Congress Transcript
Good morning, everyone, and thank you for joining the Agios EHA Investor Event. (Operator Instructions)
Also, I want to note that a copy of the slide deck is available on the Agios Investor Relations section of the Agios website.
I will now turn the call over to Jackie.
Thanks, Steve. I think we're going to show our forward-looking statements real quick first. Thanks, everybody, for joining us this morning or this afternoon, depending on what time zone you're in. We appreciate your interest in our story.
So here is today's agenda. I'll be very brief with my opening remarks, and then I'll turn it over to our Chief Medical Officer, Dr. Chris Bowden, who will go through mitapivat's mechanism of action for you. And he will also speak about the burden of pyruvate kinase deficiency, and you'll find that one of our abstracts and presentations for EHA is exactly on that topic, and it's part of the overall story of why we think mitapivat's going to be an important
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
